Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Conclusions
The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Bai, C., Chotirmall, S. H., Rello, J., Alba, G. A., Ginns, L. C., Krishnan, J. A., Rogers, R., Bendstrup, E., Burgel, P.-R., Chalmers, J. D., Chua, A., Crothers, K. A., Duggal, A., Kim, Y. W., Laffey, J. G., Luna, C. M., Niederman, M. S., Raghu, G., Ramir Tags: Respiratory infections and tuberculosis Reviews Source Type: research
More News: Anxiety | Clinical Trials | Coronavirus | COVID-19 | Depression | Dexamethasone | Hydroxychloroquine | Pneumonia | Post Traumatic Stress Disorder | Respiratory Medicine | SARS | Tuberculosis